1.Study on acting mechanism of shenqi yiqi drop pill for intervening irido-microangiopathy in diabetic rats.
Ming JIN ; Hai-dan LIU ; You-hua ZHANG
Chinese Journal of Integrated Traditional and Western Medicine 2010;30(2):174-177
OBJECTIVEUse laser confocal microscopy overspeed camera technique and fluorescence albumin labeling to study the acting mechanism of Qishen Yiqi Drop Pill (QYDP) for intervening irido-microangiopathy (IMAP) in diabetic rats.
METHODSRat model of diabetes mellitus type 1 (DM1) was established by intraperitoneal injection of streptozocin (STZ). The model rats were randomly divided into three groups, the treatment group, the model group and the control group. At the same time a normal control group was set up. The treatment group was medicated with QYDP (prepared into liquid form), and the control group with Duobeisi liquor (1 g/kg per day) for 10 months. The dynamic state of iris microcirculation in rats was observed using laser confocal microscopy overspeed camera.
RESULTSCompared with the treatment group, blood flow in iris of model rats was slower significantly (P < 0.01); the fluorescence density and leakage area of inside and outside iris vessels, and the iris vascular diameter were significantly higher in the model group than those in the treatment group (P < 0.01).
CONCLUSIONQYDP has definite effect in improving iris microcirculation, which can accelerate the blood flow, inhibit the abnormal expansion of vessels and improve the increased iris micro-vascular permeability.
Animals ; Capillary Permeability ; drug effects ; Diabetes Mellitus, Experimental ; complications ; drug therapy ; Diabetes Mellitus, Type 1 ; complications ; drug therapy ; Drugs, Chinese Herbal ; pharmacology ; therapeutic use ; Iris ; blood supply ; Iris Diseases ; etiology ; prevention & control ; Male ; Phytotherapy ; Rats ; Rats, Sprague-Dawley
2.Regression of Iris Neovascularization after Subconjunctival Injection of Bevacizumab.
Na Kyung RYOO ; Eun Ji LEE ; Tae Woo KIM
Korean Journal of Ophthalmology 2013;27(4):299-303
To describe three cases of neovascular glaucoma (NVG) where iris or angle neovascularization regressed remarkably after subconjunctival bevacizumab injections used as the initial treatment before pan retinal photocoagulation (PRP) and/or filtering surgery. Three consecutive NVG patients whose intraocular pressure (IOP) was not controlled with maximal medication were offered an off-label subconjunctival injection of bevacizumab (2.5-3.75 mg/0.1-0.15 mL, Avastin). Bevacizumab was injected into the subconjunctival space close to the corneal limbus in two or three quadrants using a 26-gauge needle. Serial anterior segment photographs were taken before and after the injection. Following subconjunctival injection of bevacizumab, iris or angle neovascularization regressed rapidly within several days. Such regression was accompanied by lowering of IOP in all three cases. The patients underwent subsequent PRP and/or filtering surgery, and the IOP was further stabilized. Our cases demonstrate that subconjunctival bevacizumab injection can be potentially useful as an initial treatment in NVG patients before laser or surgical treatment.
Adult
;
Angiogenesis Inhibitors/*administration & dosage
;
Antibodies, Monoclonal, Humanized/*administration & dosage
;
*Conjunctiva
;
Glaucoma, Neovascular/*drug therapy
;
Humans
;
Injections, Intraocular
;
Iris Diseases/*drug therapy
;
Male
;
Middle Aged
;
Treatment Outcome
3.Diagnosis & Treatment of Retinoblastoma: Current Review
Clinical Pediatric Hematology-Oncology 2015;22(1):38-47
Retinoblastoma is a rare disease, but most common tumor which arises in eye. It can affect one or both eyes, and the main pathophysiology is explained by the "Two-hit theory" - the germline mutation of the RB1 gene. Most common clinical symptoms are leuocoria, strabismus, poor visual tracking, glaucoma, and orbital cellulitis. Diagnosis is made by ophthalmologist through fundoscopic examination; Examination under General Anesthesia (EUA) is recommended until the age 3. Orbital CT and MRI can detect the tumor invasion on optic nerve, central nervous system. CSF studies, examination of bone is helpful if the distant metastasis is suspected. Biopsy is rarely done unless in the case of enucleation. Enucleated eye should be explored for the invasion to the optic nerve, choroid, anterior chamber, iris and pupil. Treatment strategies can be different according to the disease status. If the single eye is involved, the treatment goal will be the removal of tumor and prevention of relapse. Local therapies include cryotherapy, laser photocoagulation, thermotherapy can be the choice, and if the tumor is too large for the local therapy, enucleation should be concerned. Nowadays, chemo-reduction combined with local therapy, intra-arterial and intravitreous chemotherapeutic agent injections are studied to avoid enucleation. In bilateral retinoblastoma, multidisciplinary treatments include chemoreduction, external beam radiotherapy, local therapy and other experimental therapies are needed: like intra-arterial injection, intra-vitreal injection, and high-dose chemotherapy with autologous stem cell transplantation. Early detection of retinoblastoma is important to save the vision and eyeball.
Anesthesia, General
;
Anterior Chamber
;
Biopsy
;
Central Nervous System
;
Choroid
;
Cryotherapy
;
Diagnosis
;
Drug Therapy
;
Eye Enucleation
;
Germ-Line Mutation
;
Glaucoma
;
Hyperthermia, Induced
;
Injections, Intra-Arterial
;
Intravitreal Injections
;
Iris
;
Light Coagulation
;
Magnetic Resonance Imaging
;
Neoplasm Metastasis
;
Optic Nerve
;
Orbit
;
Orbital Cellulitis
;
Pupil
;
Radiotherapy
;
Rare Diseases
;
Recurrence
;
Retinoblastoma
;
Stem Cell Transplantation
;
Strabismus
;
Therapies, Investigational